Skip to main content
SpringerLink
Log in

Other Cardiovascular Drugs

  • Chapter
  • First Online:
Adverse Cutaneous Drug Reactions to Cardiovascular Drugs

  • 883 Accesses

Abstract

Other cardiovascular drugs not classified in the former sections include alpha-1 adrenergic receptor blockers, sympathomimetics, adrenergic neuron and ganglionic blockers, and drugs that are classified under the section of miscellaneous drugs, i.e., antiarrhythmic drugs like adenosine and digitalis glycosides, pentoxifylline, aminocaproic acid, protamine sulfate, and newer antianginal drugs such as ivabradine, ranolazine, and trimetazidine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marshall AJ, McGraw ME, Barritt DW. Positive antinuclear factor tests with prazosin. Br Med J. 1979;1:165–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Wilson JD, Bullock JY, Booth RJ. Influence of prazosin on the development of antinuclear antibodies in hypertensive patients. Clin Pharmacol Ther. 1979;26:209–12.

    CAS  PubMed  Google Scholar 

  3. Melkild A, Gaarder PI. Does prazosin induce formation of antinuclear factor? Br Med J. 1979;1:620–1.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Wilson JD, Booth RJ, Bullock JY. Antinuclear factor in patients on prazosin. Br Med J. 1979;1:553–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Hernandez-Cano N, Herranz P, Lazaro TE, Mayor M, Casado M. Severe cutaneous reaction due to terazosin. Lancet. 1998;352:202–3.

    Article  CAS  PubMed  Google Scholar 

  6. Torpet LA, Kragelund C, Reibel J, Nauntofte B. Oral adverse drug reactions to cardiovascular drugs. Crit Rev Oral Biol Med. 2004;15:28–46.

    Article  PubMed  Google Scholar 

  7. Koh MJ, Seah PP, Tay YK, Mancer K. Lichenoid drug eruption to terazosin. Br J Dermatol. 2008;158:426–7.

    Article  CAS  PubMed  Google Scholar 

  8. Speck LM, Wilkerson MG, Perri AJ, Kelly BC. Acute generalized exanthematous pustulosis caused by terazosin hydrochloride. J Drugs Dermatol. 2008;7:395–7.

    PubMed  Google Scholar 

  9. The Treatment of Mild Hypertension Research Group. The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med. 1991;151:1413–23.

    Article  Google Scholar 

  10. Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, et al. Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2006;8:649–56; quiz 657–8.

    Article  Google Scholar 

  11. Litt JZ. Drug eruption reference manual. 19th ed. Boca Raton: CRC Press (Taylor and Francis Group); 2013.

    Google Scholar 

  12. Raison-Peyron N, Du Thanh A, Demoly P, Guillot B. Long-lasting allergic contact blepharoconjunctivitis to phenylephrine eyedrops. Allergy. 2009;64:657–8.

    Article  CAS  PubMed  Google Scholar 

  13. Bhosale GP, Shah VR. Extravasation injury due to dopamine infusion leading to dermal necrosis and gangrene. J Anaesthesiol Clin Pharmacol. 2012;28:534–5.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Kim SM, Aikat S, Bailey A. Well recognised but still overlooked: norepinephrine extravasation. BMJ Case Rep. 2012. doi:10.1136/bcr-2012-006836.

    PubMed Central  Google Scholar 

  15. van der Rijt R, Martin-Smith JD, Clover AJ. Reversal of hand peripheral ischaemia due to extravasation of adrenaline during cardiopulmonary resuscitation. J Plast Reconstr Aesthet Surg. 2013;66:e260–3.

    Article  PubMed  Google Scholar 

  16. Wu CC, Chen WJ, Cheng JJ, Hsieh YY, Lien WP. Local dermal hypersensitivity from dobutamine hydrochloride (Dobutrex solution) injection. Chest. 1991;99:1547–8.

    Article  CAS  PubMed  Google Scholar 

  17. Tsai Pai MA, Chien SW, Kuo YC, Wu TK, Chen CH, Lim PS. Symmetrical peripheral gangrene after using high-dose inotropes. Acta Nephrologica. 2013;27:48–51.

    Google Scholar 

  18. Colak T, Erdogan O, Yerebakan O, Arici C, Gurkan A. Symmetrical peripheral gangrene and dopamine. Ulus Travma Acil Cerrahi Derg. 2003;9:222–4.

    PubMed  Google Scholar 

  19. Hayes MA, Yau EH, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med. 1992;18:433–6.

    Article  CAS  PubMed  Google Scholar 

  20. Joynt G, Doedens L, Lipman J, Bothma P. High-dose adrenaline with low systemic vascular resistance and symmetrical peripheral gangrene. S Afr J Surg. 1996;34:99–101.

    CAS  PubMed  Google Scholar 

  21. Winkler MJ, Trunkey DD. Dopamine gangrene. Association with disseminated intravascular coagulation. Am J Surg. 1981;142:588–91.

    Article  CAS  PubMed  Google Scholar 

  22. López Abad R, Iriarte Sotés P, Castro Murga M, Gracia Bara MT, Sesma Sánchez P. Fixed drug eruption induced by phenylephrine: a case of polysensitivity. J Investig Allergol Clin Immunol. 2009;19:322–3.

    PubMed  Google Scholar 

  23. Tsuchimoto T, Miyazaki H, Suzuki E, Maekawa N. Case report: severe anaphylactic shock followed by positive skin-prick-test to multiple vasoconstrictors. Masui. 2010;59:788–91.

    PubMed  Google Scholar 

  24. Parsaik AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, Murad MH. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013;28:1496–503.

    Article  PubMed Central  PubMed  Google Scholar 

  25. McCauley CS, Blumenthal MS. Dobutamine and pruritus of the scalp. Ann Intern Med. 1986;105:966.

    Article  CAS  PubMed  Google Scholar 

  26. Ross M. Dopamine-induced localized cutaneous vasoconstriction and piloerection. Arch Dermatol. 1991;127:586–7.

    Article  CAS  PubMed  Google Scholar 

  27. Baumgart D, Buck T, Leischik R, Oelert H, Farahati J, Reiners C, Erbel R. Enoximon-echocardiography. A new diagnostic approach for the detection of viable myocardium comparison to dobutamin-echocardiography. Herz. 1994;19:227–34.

    CAS  PubMed  Google Scholar 

  28. Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part III. Cardiol Rev. 2002;10:337–48.

    Article  PubMed  Google Scholar 

  29. Almeyda J, Levantine A. Cutaneous reactions to cardiovascular drugs. Br J Dermatol. 1973;88:313–9.

    Article  CAS  PubMed  Google Scholar 

  30. Frishman WH, Brosnan BD, Grossman M, Dasgupta D, Sun DK. Adverse dermatologic effects of cardiovascular drug therapy: part II. Cardiol Rev. 2002;10:285–300.

    Article  PubMed  Google Scholar 

  31. Martin SJ, Shah D. Cutaneous hypersensitivity reaction to digoxin. JAMA. 1994;271:1905.

    Article  CAS  PubMed  Google Scholar 

  32. David M, Livni E, Stern E, Feuerman EJ, Grinblatt J. Psoriasiform eruption induced by digoxin: confirmed by re-exposure. J Am Acad Dermatol. 1981;5:702–3.

    Article  CAS  PubMed  Google Scholar 

  33. Berger H. Thrombopenic purpura following use of digitoxin. J Am Med Assoc. 1952;148:282–3.

    Article  CAS  PubMed  Google Scholar 

  34. Gonzalez-Mahave I, Del Pozo MD, Blasco A, Lobera T, Venturini M. Urticaria due to pentoxyfylline. Allergy. 2005;60:705.

    Article  CAS  PubMed  Google Scholar 

  35. Seoane-Lestón FJ, Añibarro-Bausela MB, Mugíca-García MV, Aguilar-Martínez A. Urticaria caused by pentoxifylline. J Investig Allergol Clin Immunol. 2009;19:74–5.

    PubMed  Google Scholar 

  36. Patrizi A, Tabanelli M, Antonucci A, Neri I. Acute generalized exanthematous pustulosis induced by pentoxifylline. Int J Dermatol. 2007;46:1310–2.

    Article  PubMed  Google Scholar 

  37. Saunderson RB, Garsia R, Headley AP, McCaughan GW, O’Toole S, Strasser SI. Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance. J Dermatol Case Rep. 2013;7:77–81.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Gonzalez Gutierrez ML, Esteban Lopez MI, Ruiz Ruiz MD. Positivity of patch tests in cutaneous reaction to aminocaproic acid: two case reports. Allergy. 1995;50:745–6.

    Article  CAS  PubMed  Google Scholar 

  39. Villarreal O. Systemic dermatitis with eosinophilia due to epsilon-aminocaproic acid. Contact Dermatitis. 1999;40:114.

    Article  CAS  PubMed  Google Scholar 

  40. Cunha D, Carvalho R, Santos R, Cardoso J. Systemic allergic dermatitis to epsilon-aminocaproic acid. Contact Dermatitis. 2009;61:303–4.

    Article  PubMed  Google Scholar 

  41. Chakrabarti A, Collett KA. Purpuric rash due to epsilon-aminocaproic acid. Br Med J. 1980;281:197–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Brooke CP, Spiers EM, Omura EF. Noninflammatory bullae associated with epsilon-aminocaproic acid infusion. J Am Acad Dermatol. 1992;27:880–2.

    Article  CAS  PubMed  Google Scholar 

  43. Miyamoto H, Okajima M. Allergic contact dermatitis from epsilon-aminocaproic acid. Contact Dermatitis. 2000;42:50.

    CAS  PubMed  Google Scholar 

  44. Yien HW, Hseu SS, Chan KH, Lee TY. Suspected anaphylactoid shock to aminocaproic acid (plaslloid) during operation. Zhonghua Yi Xue Za Zhi (Taipei). 1992;50:415–9.

    CAS  Google Scholar 

  45. Nybo M, Madsen JS. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol. 2008;103:192–6.

    Article  CAS  PubMed  Google Scholar 

  46. Ford SA, Kam PC, Baldo BA, Fisher MM. Anaphylactic or anaphylactoid reactions in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 2001;15:684–8.

    Article  CAS  PubMed  Google Scholar 

  47. Roelofse JA, van der Bijl P. An anaphylactic reaction to protamine sulfate. Anesth Prog. 1991;38:99–100.

    CAS  PubMed Central  PubMed  Google Scholar 

  48. Jones DA, Timmis A, Wragg A. Novel drugs for treating angina. BMJ. 2013;347:f4726.

    Article  PubMed  Google Scholar 

  49. Chaturvedi A, Singh Y, Chaturvedi H, Thawani V, Singla S, Parihar D. Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris. J Pharmacol Pharmacother. 2013;4:33–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Venereology, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey

    Esen Özkaya & Kurtuluş Didem Yazganoğlu

Authors
  1. Esen Özkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurtuluş Didem Yazganoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Özkaya, E., Yazganoğlu, K.D. (2014). Other Cardiovascular Drugs. In: Adverse Cutaneous Drug Reactions to Cardiovascular Drugs. Springer, London. https://doi.org/10.1007/978-1-4471-6536-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6536-1_15

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6535-4

  • Online ISBN: 978-1-4471-6536-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation